Navigation Links
KaloBios to Present at Stifel Healthcare Conference 2013
Date:9/5/2013

SOUTH SAN FRANCISCO, Calif., Sept. 5, 2013 /PRNewswire/ -- KaloBios Pharmaceuticals (Nasdaq: KBIO) today announced that the company will present at the Stifel Healthcare Conference 2013 on September 12 at the Four Seasons Hotel in Boston. KaloBios President and Chief Executive Officer, David W. Pritchard, will provide an overview of KaloBios and the company's three current clinical programs for its proprietary, patient-targeted monoclonal antibody therapeutics.

(Logo: http://photos.prnewswire.com/prnh/20130225/MM66380LOGO)

Company Presentation:
When: Thursday, September 12, 2013, 9:10 AM EDT
Where: The Four Seasons Hotel, Boston, MA

Webcast:
To access the live and archived audio webcast of the Stifel presentation please log on through a link located in the Investors section of the KaloBios Pharmaceuticals website under the Events & Presentations tab: http://www.veracast.com/webcasts/stifel/healthcare2013/02203595823.cfm.

A replay of the webcast will be available one hour after the conclusion of the live event. 

About KaloBios
KaloBios Pharmaceuticals, Inc. is developing a portfolio of patient-targeted, first-in-class monoclonal antibodies to treat severe medical conditions with a primary clinical focus on respiratory diseases and cancer.  For more information on KaloBios Pharmaceuticals, please visit our web site at http://www.kalobios.com.

Contact:

Jeffrey H. Cooper
Chief Financial Officer
KaloBios Pharmaceuticals, Inc.
(650) 243-3146
ir@kalobios.com

Media Contact:

Joan E. Kureczka
Kureczka/Martin Associates
Tel:  (415) 821-2413
Mobile: (415) 690-0210
Joan@Kureczka-Martin.com


'/>"/>
SOURCE KaloBios Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. KaloBios Pharmaceuticals Announces Pricing of Initial Public Offering
2. KaloBios Pharmaceuticals Completes Initial Public Offering
3. KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma Data from KB002 Phase 1/2 Study Presented at the American Academy of Allergy, Asthma and Immunology Meeting
4. KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma
5. Bioassociate Announces Initiation of Coverage on KaloBios Pharmaceuticals, Inc.
6. KaloBios to Present at Future Leaders in the Biotech Industry Conference
7. KaloBios Targeted Antibacterial KB001-A to be Featured in BIO 2013 Panel Discussion of "New Defenses Against Old Enemies"
8. KaloBios to Present at Needham Healthcare Conference
9. KaloBios Reports First Quarter 2013 Financial Results
10. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
11. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2019)... N.C. (PRWEB) , ... December 06, 2019 , ... ... nonprofit funder of global MSA research, recently unveiled its bold new initiative to ... that strikes in the middle-years of life. , Infused by $3 million in ...
(Date:12/5/2019)... ... December 05, 2019 , ... ... Web Services (AWS) Public Sector Partner Program; a designation that will accelerate ... recognizes and collaborates with partners that offer solutions and proven experience delivering ...
(Date:12/5/2019)... FRANCISCO (PRWEB) , ... December 05, 2019 , ... ... biopharma leaders through off-the-record collaboration and dialogue, today announces key issues to be ... 2020 at the Four Seasons Hotel in San Francisco. ...
Breaking Medicine Technology:
(Date:12/5/2019)... , ... December 05, 2019 , ... ... planning, has announced the Top 54 RHIT Degree Programs for 2020. The comprehensive ... in the nation. Each program is evaluated based on curriculum quality, graduation rate, ...
(Date:12/4/2019)... CARDIFF BY THE SEA, Calif. (PRWEB) , ... ... ... Prickly Pear fruit, trademarked as Tex-OE, Opuntia Mesocarp Extract®, provides protection from disruptions ... amazing extract, effective at countering the menace of Jet Lag, is available in ...
(Date:12/4/2019)... ... December 04, 2019 , ... UNC Health Care has introduced a new ... the campuses of UNC Medical Center in Chapel Hill and UNC REX Healthcare in ... and more. , The free interactive app, developed by Gozio Health, also gives patients ...
(Date:12/2/2019)... ... ... Interim HealthCare Inc. , a national franchisor of home care, hospice and ... Selected for its multi-pronged approach to building a strong workforce, Interim HealthCare’s commitment to ... 2025, the U.S. will need to hire 2.5 million new healthcare workers to care ...
(Date:11/30/2019)... (PRWEB) , ... November 29, 2019 , ... NJ Top ... in various orthopedic physician leadership positions. He has gained tremendous recognition and has received ... ankle surgery. Dr. Kovatis treats all aspects of lower extremity orthopedics. Through his training ...
Breaking Medicine News(10 mins):